Lisa Matar is a Global Life Science executive with more than 25 years of experience leading organizations and driving significant growth, profitability, and launching excellence across the globe.
Lisa served as President and General Manager of Eli Lilly Canada from 2013 to February 2020 and was a member of the North American executive committee at Eli Lilly. Lisa served on the Board of Directors of Innovative Medicine Canada from 2013 until early 2020 and chaired the Ethics and Compliance committee from 2018 to 2020.
Lisa is a strong advocate for innovation with emphasis on change management, diversity, and inclusion.
Lisa earned a Doctorate in pharmacy from the University of Saint Joseph in Lebanon.
Lisa currently also serves on the board of Directors of Starpax Biopharma Inc. Starpax Biopharma Inc. is a biopharma/MedTech company that has developed a revolutionary platform for 3D precision delivery of cancer drugs in solid tumors using MagnetodronesTM.
Lisa joined Delphi Diagnostics’ Board of Directors in September 2021, chairs the compensation and governance committee, and brings extensive commercial and leadership experience to the company.